X-ray-Triggered Self-Sustaining Afterglow Scaffolds with Persistent Type-I/II ROS Generation for Imaging-Guided Hypoxic Tumor Therapy
In the authors' words
This journal does not let us republish the full abstract. Here are the two sentences Pipette selected, quoted from it. Read the rest at the publisher.
Main result
A tumor-activatable derivative (BTBR) with H2O2-responsive boronate caging achieves high-contrast, tumor-specific afterglow imaging (signal-to-background ratio > 120) and enables hypoxic tumor ablation (95.8% inhibition) with real-time afterglow monitoring.
Appeared: Sunday, October 11. Journal of the American Chemical Society. Peer-reviewed journal.
DOI: 10.1021/jacs.6c18200